Shona Ritchie

Had a fantastic time at @myueg.bsky.social week in Berlin, sharing science and meeting new colleagues/pals!

Huge thanks to @metastasisresearch.bsky.social for making it possible for me to attend and share our research

Temporally resolved proteomics identifies nidogen-2 as a cotarget in pancreatic cancer that modulates fibrosis and therapy response Temporal mass spectrometry proteomics, advanced microscopy, and in vivo modeling reveal nidogen-2 as a cotarget in PDAC.

Congratulations to @mbsanz.bsky.social MCR Paper of the Year 2024 Recipients, Brooke Pereira & Shona Ritchie, (co-led by @tcox.bsky.social ), for their latest work looking at the role of Nidogen-2 in pancreatic cancer published in Science Advances!

www.science.org/doi/10.1126/...

2024 Career Support Funds Granted Find out more about the recipients of the 2024 Career Support Grants and their research projects.

Honoured to be a recipient in this incredible cohort:
www.cancer.nsw.gov.au/research-and...

Thank you CINSW! 🌟

🥳 So happy to share I’ve been awarded a Cancer Institute NSW Fellowship! This will support my work on investigating metabolic perturbations in pancreatic cancer with the Timpson Lab

@garvaninstitute.bsky.social
@cancerecogarvan.bsky.social

Targeting the NPY/NPY1R signaling axis in mutant p53–dependent pancreatic cancer impairs metastasis Targeting NPY1R reduces mutant p53–dependent pancreatic cancer metastasis.

Excited to kick off my Bluesky posting by sharing this work by the lab looking at the role of neuropeptideY in #pancreaticcancer metastasis. An amazing piece of work and so thrilled to see it finally out!

@garvaninstitute.bsky.social

www.science.org/doi/10.1126/...